Trump favoring cutting off ACA subsidies to insurers

President Donald Trump is reportedly leaning towards ending cost-sharing reduction subsidies, or CSRs, to insurers offering coverage on the Affordable Care Act (ACA) exchanges, which could quickly destabilize the marketplace.

POLITICO reports Trump expressed his desire to end the payments in a May 16 meeting in the Oval Office. While others in the administration, including HHS Secretary Tom Price, MD, are wary of such a move because of the political consequences and how it would discourage insurers from participating in the exchanges, Trump feels the “bold move” would force Democrats in Congress to negotiate a replacement for the ACA, despite party members’ statements otherwise.  

Trump has been encouraged by groups outside the administration to preserve the subsidies. The National Association of Insurance Commissioners has said the ongoing uncertainty around the CSRs could lead many insurers to drop ACA participation in 2018. The attorneys general of 15 states have signed on to intervene in the lawsuit threatening the subsidies. If they are eliminated, a Kaiser Family Foundation study said federal healthcare spending would go up, not down.

Read the full article at the link below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”